Gonadotropin-Releasing Hormone Agonist Analog (Nafarelin): A Useful Diagnostic Agent for the Distinction of Constitutional Growth Delay from Hypogonadotropic Hypogonadism

Gad B. Kletter,; Alice Rolfes-Curl,; Jessie C. Goodpasture,; Sharyn B. Solish,; Linda Scott,; Milan R. Henzl,; Inese Z. Beitins,

doi:10.1515/JPEM.1996.9.1.9

Home Gonadotropin-Releasing Hormone Agonist Analog (Nafarelin): A Useful Diagnostic Agent for the Distinction of Constitutional Growth Delay from Hypogonadotropic Hypogonadism

Article

Licensed

Unlicensed Requires Authentication

Gonadotropin-Releasing Hormone Agonist Analog (Nafarelin): A Useful Diagnostic Agent for the Distinction of Constitutional Growth Delay from Hypogonadotropic Hypogonadism

Gad B. Kletter, , Alice Rolfes-Curl, , Jessie C. Goodpasture, , Sharyn B. Solish, , Linda Scott, , Milan R. Henzl, and Inese Z. Beitins,

Published/Copyright: January 1, 1996

Published by

Become an author with De Gruyter Brill

Submit Manuscript Author Information Explore this Subject

From the journal Journal of Pediatric Endocrinology and Metabolism Volume 9 Issue 1

MLA
APA
Harvard
Chicago
Vancouver

MLA
APA
Harvard
Chicago
Vancouver

Kletter,, Gad B., Rolfes-Curl,, Alice, Goodpasture,, Jessie C., Solish,, Sharyn B., Scott,, Linda, Henzl,, Milan R. and Beitins,, Inese Z.. "Gonadotropin-Releasing Hormone Agonist Analog (Nafarelin): A Useful Diagnostic Agent for the Distinction of Constitutional Growth Delay from Hypogonadotropic Hypogonadism" Journal of Pediatric Endocrinology and Metabolism, vol. 9, no. 1, 1996, pp. 9-20. https://doi.org/10.1515/JPEM.1996.9.1.9

Kletter,, G., Rolfes-Curl,, A., Goodpasture,, J., Solish,, S., Scott,, L., Henzl,, M. & Beitins,, I. (1996). Gonadotropin-Releasing Hormone Agonist Analog (Nafarelin): A Useful Diagnostic Agent for the Distinction of Constitutional Growth Delay from Hypogonadotropic Hypogonadism. Journal of Pediatric Endocrinology and Metabolism, 9(1), 9-20. https://doi.org/10.1515/JPEM.1996.9.1.9

Kletter,, G., Rolfes-Curl,, A., Goodpasture,, J., Solish,, S., Scott,, L., Henzl,, M. and Beitins,, I. (1996) Gonadotropin-Releasing Hormone Agonist Analog (Nafarelin): A Useful Diagnostic Agent for the Distinction of Constitutional Growth Delay from Hypogonadotropic Hypogonadism. Journal of Pediatric Endocrinology and Metabolism, Vol. 9 (Issue 1), pp. 9-20. https://doi.org/10.1515/JPEM.1996.9.1.9

Kletter,, Gad B., Rolfes-Curl,, Alice, Goodpasture,, Jessie C., Solish,, Sharyn B., Scott,, Linda, Henzl,, Milan R. and Beitins,, Inese Z.. "Gonadotropin-Releasing Hormone Agonist Analog (Nafarelin): A Useful Diagnostic Agent for the Distinction of Constitutional Growth Delay from Hypogonadotropic Hypogonadism" Journal of Pediatric Endocrinology and Metabolism 9, no. 1 (1996): 9-20. https://doi.org/10.1515/JPEM.1996.9.1.9

Kletter, G, Rolfes-Curl, A, Goodpasture, J, Solish, S, Scott, L, Henzl, M, Beitins, I. Gonadotropin-Releasing Hormone Agonist Analog (Nafarelin): A Useful Diagnostic Agent for the Distinction of Constitutional Growth Delay from Hypogonadotropic Hypogonadism. Journal of Pediatric Endocrinology and Metabolism. 1996;9(1): 9-20. https://doi.org/10.1515/JPEM.1996.9.1.9

Copy

Copied to clipboard

BibTeX EndNote RIS

Published Online: 1996-01

You are currently not able to access this content.

Articles in the same Issue

TABLE OF CONTENTS
LETTER FROM THE EDITORS
Limited Joint Mobility in Children with Type 1 Diabetes Mellitus. A Critical Review
Gonadotropin-Releasing Hormone Agonist Analog (Nafarelin): A Useful Diagnostic Agent for the Distinction of Constitutional Growth Delay from Hypogonadotropic Hypogonadism
Growth Promoting Peptides in Diabetic and Non-Diabetic Pregnancy: Interactions with Trophoblastic Receptors and Serum Carrier Proteins
Skeletal Dysplasias: Response to Growth Hormone Therapy
Reproducibility and Comparison of Growth Hormone Secretion Tests
Growth in Children after Bone Marrow Transplantation for Acute Myelogenous Leukemia as Compared to Acute Lymphocytic Leukemia
Bone Mass in Children with Congenital Hypothyroidism Treated with Thyroxine Since Birth
Thyroid Hormone and Attention in Congenital Hypothyroidism
Sex Reversal in an Infant with Smith-Lemli-Opitz Syndrome, Type II: Evidence for 5-alpha Reductase Deficiency
BOOK REVIEW

Search journal Search the content of this journal

https://doi.org/10.1515/JPEM.1996.9.1.9

Articles in the same Issue

TABLE OF CONTENTS
LETTER FROM THE EDITORS
Limited Joint Mobility in Children with Type 1 Diabetes Mellitus. A Critical Review
Gonadotropin-Releasing Hormone Agonist Analog (Nafarelin): A Useful Diagnostic Agent for the Distinction of Constitutional Growth Delay from Hypogonadotropic Hypogonadism
Growth Promoting Peptides in Diabetic and Non-Diabetic Pregnancy: Interactions with Trophoblastic Receptors and Serum Carrier Proteins
Skeletal Dysplasias: Response to Growth Hormone Therapy
Reproducibility and Comparison of Growth Hormone Secretion Tests
Growth in Children after Bone Marrow Transplantation for Acute Myelogenous Leukemia as Compared to Acute Lymphocytic Leukemia
Bone Mass in Children with Congenital Hypothyroidism Treated with Thyroxine Since Birth
Thyroid Hormone and Attention in Congenital Hypothyroidism
Sex Reversal in an Infant with Smith-Lemli-Opitz Syndrome, Type II: Evidence for 5-alpha Reductase Deficiency
BOOK REVIEW